Millennials favor direct mail over email marketing
BOSTON (PRWEB) November 12, 2019
ClinicalConnection.com, specializing in digital patient recruitment for clinical trials is now providing direct mail patient recruitment advertising as a complement to its web-based services. Leveraging its patient database of more than 650,000 members, this new offering enables community-based Clinical Research Centers and other stakeholders to deliver at-home information about clinical trials for which they are actively recruiting patients.
“With one of the most robust and highly-vetted patient communities in the industry, we are pleased to expand the scope of our clinical research recruitment services,” said Greg Conlan, Director of Operations. “Every one of our members has been very specific about which diseases or medical conditions from A to Z are of interest to them – enabling us to use both direct mail and digital approaches to geo-target patient populations.”
The rationale for using multi-channel advertising to deliver content to consumers has been reported in Forbes. Forbes stated that an effort which “leverages the unique benefits of paper with the convenience and accessibility of digital will perform best.” Forbes also cited studies showing that Millennials favor direct mail (38%) over email marketing (26%), check their physical mailbox each day, and spend more time going through mail they receive including direct mail material.
Those interested in ClinicalConnection’s direct mail advertising solution can call, 800-887-0639.
Headquartered in Boston, Massachusetts, ClinicalConnection provides a suite of new patient recruiting services designed to help the clinical trials industry meet enrollment goals for clinical research studies. Clients include pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations (CROs), academic and independent clinical research centers, hospitals and physician practices engaged in clinical research. ClinicalConnection.com has listed over 40,000 clinical trials and sent more than one million referrals to clinical research studies.